ImmunityBio Inc

IBRXNASDAQ · USD
7.81USD0.00 (-4.99%)
1210

ImmunityBio Inc (IBRX) Straddle

IBRX straddle scan found 84 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 66.9%.

Read more

Trading a IBRX straddle lets you take a pure volatility position on ImmunityBio Inc without committing to a direction. ImmunityBio Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IBRX straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on IBRX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ImmunityBio Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IBRX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co.

Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the IBRX straddle is the cleanest expression of that view. Our scanner prices every IBRX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IBRX straddle into a catalyst or short a IBRX straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 19, 202920.00$15.0381928%66.9%$35.03$4.980
Jan 21, 202822.00$15.4845528%63.7%$37.48$6.5356
Nov 20, 202612.00$3.432828%61.7%$15.43$8.5899
Mar 17, 202815.00$9.9051128%60.7%$24.90$5.1019
Jan 19, 202915.00$11.3881928%60.7%$26.38$3.638
Jan 21, 202820.00$14.1345528%60.5%$34.13$5.8837
Jan 21, 202815.00$9.8345528%58.8%$24.83$5.18610
Jan 15, 202711.00$3.458428%58.6%$14.45$7.55160
Mar 17, 202810.00$6.1551128%57.4%$16.15$3.8520
Mar 17, 202820.00$15.0351128%56.8%$35.03$4.980

As of October 23, 2026

Find the right straddle before volatility moves

Track IBRX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial